Los Angeles Capital Management LLC Acquires 13,847 Shares of DaVita Inc. $DVA

Los Angeles Capital Management LLC raised its holdings in DaVita Inc. (NYSE:DVA) by 132.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,322 shares of the company’s stock after acquiring an additional 13,847 shares during the quarter. Los Angeles Capital Management LLC’s holdings in DaVita were worth $2,888,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. NewEdge Advisors LLC lifted its stake in shares of DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after purchasing an additional 88 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of DaVita by 34.9% in the third quarter. Smartleaf Asset Management LLC now owns 452 shares of the company’s stock worth $59,000 after buying an additional 117 shares during the last quarter. Bank of Nova Scotia boosted its stake in shares of DaVita by 2.5% during the 3rd quarter. Bank of Nova Scotia now owns 4,933 shares of the company’s stock worth $655,000 after acquiring an additional 120 shares in the last quarter. Daiwa Securities Group Inc. increased its holdings in shares of DaVita by 2.2% during the 2nd quarter. Daiwa Securities Group Inc. now owns 6,502 shares of the company’s stock valued at $926,000 after acquiring an additional 138 shares during the last quarter. Finally, State of Wyoming raised its stake in shares of DaVita by 6.0% in the 2nd quarter. State of Wyoming now owns 2,759 shares of the company’s stock valued at $393,000 after acquiring an additional 156 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Truist Financial upped their target price on DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a research report on Friday, May 8th. Deutsche Bank Aktiengesellschaft upgraded shares of DaVita from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $126.00 to $220.00 in a research note on Wednesday, May 6th. TD Cowen raised their target price on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Barclays lifted their target price on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Finally, Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $199.17.

Insider Activity

In related news, CFO Joel Ackerman sold 51,471 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the transaction, the chief financial officer directly owned 132,434 shares in the company, valued at approximately $25,440,571.40. This represents a 27.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

DaVita Stock Performance

Shares of DVA opened at $198.19 on Wednesday. The company has a 50-day simple moving average of $173.05 and a 200-day simple moving average of $144.47. DaVita Inc. has a 52 week low of $101.00 and a 52 week high of $202.69. The firm has a market capitalization of $12.72 billion, a P/E ratio of 18.39, a P/E/G ratio of 0.63 and a beta of 0.91.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.33 by $0.54. The business had revenue of $3.42 billion for the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period last year, the business earned $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts forecast that DaVita Inc. will post 15.07 earnings per share for the current year.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.